Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
R&D Should Be Outsourced Overseas To Control Development Costs – HGS CEO
May 24 2004
•
By
The Pink Sheet
More from Archive
More from Pink Sheet